George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I've faith that PHE will be paying close attention. The LAMP test comes along with Novacyt's Gold Standard test. I believe we will get an update within 2 weeks.
For all the new investors here try not to listen to these posters encouraging you to lock in profits.
Albert Einstein described Compound interest as "the eighth wonder of the world. He whounderstands it, earns it … he who doesn't … pays it.”
Novacyt can sell as many test kits as they can make, test kits will be in extreme demand for at least 6 months and likely 12, with a ramp down over a furher 6>12 months.
My advice to new investors is to monitor global testing rates, new cases and deaths. You can gauge the stage of testing market from this data. Being able to access this publicly available data levels the playing field with big finance. My portfolio is now up 50% since feb 24th, while the markets are down 30%. This is due to my checking COVID trends and understanding compounding increase of cases. I can apply the same methodology for tracking the peak and recovery from COVID ;-)
Quality Sells
Novacyts test is 100% accurate, can not be beaten on quality. A faster or cheaper test may come along and effect the share price on a given news day. But the day after any such news Novacyt will still sell all of their products and continue to fully utilise its caoacity.
I image they have sold 4m kits so far, global demand is likely to be in the order of 3.5m kits. Room for so many suppliers. Novacyt just happen to be the best in the world right now.
Short term trading is for computer algorithms and fools. If your quicker at maths than a computer good on you lol
I also make long term investments, in such a dynamic environment I would determine long term as 3>9 months. In normal markets my outlook is 4 > 10 years.
Am very happy with my £x00,000 profit in a month. Will likely hold all my shares until June and then will look at the global situation and consider selling up to half and possibly keep the remainder in for a yr. I won't be settling for a furher 30% gain.
Do your own research, take caution reading forum comments, validate when possible, don't get freaked out if price drops 20% one day nor too exited when it goes up. Don't get attached to the company, one day it will be time to move on $$$
What I am getting at with the LAMP technology, is that the assay for this test could also be provided by Primerdesign,
now that the link up with AZ and GSK is established.
The two assays do not use common chemicals I believe, but will need to double check this.
News from Optigene should be with us soon of their consultation with PHE and Govnt concerning
use of their Genie HT LAMP instrument to process 300 tests / hr.
I'm not happy with maximising sales of one assay, I want to make money out of two, but to do so LAMP technology interest needs to be ignited. BOOM - as they say in day trading circles.
All these other tests that are being mentioned are being developed and are 1-2 months away from even being ready - then what accuracy will they have. They may do very well, but significant news for them is in the future. Where will NCYT be by then in 1-2 months, with proven science, huge orders and working with the 2 biggest pharma companies in the UK.
Are GDR not already working on a qPCR?
Quickdraw - ref my 20:32 post last night.
Now that Primerdesign are to partner with the big guys at the new Cambridge laboratory,
I am hoping we can get the assay for the LAMP equipment as well as the qPCR assay on the agenda there. Not many seem to realise that the success that is evident with the qPCR assay is possibly repeatable
if the LAMP technology is of interest to PHE / Govnt, or any other foreign health authorities.
To supply an Assay, they will be turning to Primerdesign who provided the original assay.
Keep up the good work, lets hope PHE wakes up to the opportunity before others elsewhere do.
From todays 'Collaboration with AstraZeneca, GSK and University of Cambridge' RNS:
Graham Mullis, Chief Executive Officer of Novacyt, added:
"Novacyt is committed to supporting national efforts in the fight against the COVID-19 pandemic. In the UK, we continue to work with the NHS and Public Health England to supply our COVID-19 test to a growing number of hospitals and, through this new collaboration with AstraZeneca, GSK and the University of Cambridge, we are very pleased to further assist the Government to increase testing."
While it's great for the company to be contributing in the above way, that leaves less resources available for the company to contribute to any LAMP (Loop-Mediated Isothermal Amplification) test technology, - particularly the assay.
On 6th April, Michael Andreou, managing director of OptiGene said:
"The company hopes that after furnishing Public Health England with further data, its test equipment could be in use by next week" - Thats Tuesday 14th April soonest.
https://www.wscountytimes.co.uk/news/people/horsham-company-develops-rapid-new-test-coronavirus-2531127
We await news from Optigene of their consultation with PHE and Govnt concerning use of their Genie HT LAMP instrument to process 300 tests / hr.
The Cambridge Lab facility will be used for high throughput screening for COVID-19 testing and to explore the use of alternative chemical reagents for test kits in order to help overcome current supply shortages.
This statement applies to Primerdesigns qPCR assay, but could easily be modified for both qPCR and LAMP assays, with Govnt approval.
Primerdesign is now in pole position to take the conversation concerning LAMP and LAMP assay development further with PHE / Govnt.
If VanV is around, - perhaps the use of this website might assist with making information available to editors / cabinet members:
https://www.openpr.com/news/2002083/corona-virus-treatment-market-to-witness-huge-growth-by-2026-key
There is further work still to be done if we want to dominate the conversation regarding LAMP assay as well as qPCR assay.